Načítá se...
Pyrazinamide may possess cardioprotective properties
Pyrazinamide is an anti-tubercular agent, used as a part of a three-drug regime (any three of the following: rifampicin, isoniazid, pyrazinamide, streptomycin or ethambutol) for the initial phase of treatment. One of the effects pyrazinamide has on mammalian cells is to regulate NAD(+)/NADH levels....
Uloženo v:
| Vydáno v: | J Antibiot (Tokyo) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6760625/ https://ncbi.nlm.nih.gov/pubmed/31243346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41429-019-0202-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|